Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages
✍ Scribed by Kil-Nam Kim; Soo-Jin Heo; Weon-Jong Yoon; Sung-Myung Kang; Ginnae Ahn; Tae-Hoo Yi; You-Jin Jeon
- Book ID
- 113588985
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 717 KB
- Volume
- 649
- Category
- Article
- ISSN
- 0014-2999
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Roxatidine is a novel, specific, competitive H 2 -receptor antagonist that is used to treat gastric and duodenal ulcers, and which is known to suppress the growth of several tumors by reducing vascular endothelial growth factor (VEGF) expression. Nevertheless, it remains unclear whether roxatidine h
The treatment of inflammatory diseases today is largely based on interrupting the synthesis or action of the mediators that drive the host's response to injury. It is on the basis of this concept that most of the anti-inflammatory drugs have been developed. In our continuous search for novel anti-in